Recombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag
- PMID: 23989890
- PMCID: PMC3798890
- DOI: 10.3390/v5092062
Recombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag
Abstract
The HIV/AIDS epidemic remains a global health problem, especially in Sub-Saharan Africa. An effective HIV-1 vaccine is therefore badly required to mitigate this ever-expanding problem. Since HIV-1 infects its host through the mucosal surface, a vaccine for the virus needs to trigger mucosal as well as systemic immune responses. Oral, attenuated recombinant Salmonella vaccines offer this potential of delivering HIV-1 antigens to both the mucosal and systemic compartments of the immune system. So far, a number of pre-clinical studies have been performed, in which HIV-1 Gag, a highly conserved viral antigen possessing both T- and B-cell epitopes, was successfully delivered by recombinant Salmonella vaccines and, in most cases, induced HIV-specific immune responses. In this review, the potential use of Salmonella enterica serovar Typhimurium as a live vaccine vector for HIV-1 Gag is explored.
References
-
- Brenner D.J. Enterobacteriaceae. In: Krieg N.B., Holt J.G., editors. Bergey’s Manual of Systemic Bacteriology. Volume 1 Williams and Wilkins; Baltimore, MD, USA: 1984.
-
- Farmer J.J. Enterobacteriaceae: Introduction and identification. In: Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M.A., Yolken R.H., editors. Manual of Clinical Microbiology. ASM Press; Washington, DC, USA: 2003.
-
- Ohl M.E., Miller S.I. Salmonella: A model for bacterial pathogenesis. Annu. Rev. Med. 2001;52:259–274. - PubMed
-
- Miller S.I., Pegues D.A. Salmonella species, including Salmonella Typhi. In: Mandell G.L., Bennett J.E., Dolin R., editors. Principles and Practice of Infectious Diseases. Churchill Livingstone; Philadelphia, PA, USA: 2000.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
